{"id":"W4361862758","doi":"10.1183/13993003.02202-2022","title":"Not just an anti-eosinophil drug: tezepelumab treatment for type 2 asthma and beyond","year":2023,"lang":"en","type":"letter","venue":"European Respiratory Journal","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval","funders":"AstraZeneca; Amgen","keywords":"Medicine; Eosinophil; Asthma; Airway hyperresponsiveness; Drug; Immunology; Airway; Bronchial hyperresponsiveness; Pharmacology; Internal medicine; Respiratory disease; Lung; Anesthesia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008401201,0.0005759372,0.0008207376,0.000514378,0.001839232,0.001365266,0.0006704304,0.01631707,0.006861493],"category_scores_gemma":[0.004852685,0.0002842173,0.001063166,0.0003055906,0.001233686,0.002035604,0.000525802,0.01827968,0.006958996],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002598589,"about_ca_system_score_gemma":0.001386953,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002910787,"about_ca_topic_score_gemma":0.005301862,"domain_scores_codex":[0.9992061,0.0001814813,0.00007880073,0.0001051891,0.000316686,0.0001116488],"domain_scores_gemma":[0.9984965,0.0006427121,0.0001047028,0.00004652064,0.0003081031,0.0004014856],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007592108,0.00005274988,0.0004268466,0.0000658294,0.00001128882,0.003330512,0.00003930831,0.00005716375,0.0005351151,0.002096319,0.9740396,0.01926925],"study_design_scores_gemma":[0.0002277487,0.0001827708,0.001599452,0.0005102845,0.00003290278,0.01329156,0.0001392034,0.0004827743,0.0003285062,0.009078466,0.9740772,0.00004908488],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.0006624312,0.005428041,0.0001397173,0.9696688,0.01813575,0.00001111808,0.00005541025,0.0000476327,0.005851075],"genre_scores_gemma":[0.006206419,0.006144315,0.0003880872,0.900637,0.06995907,0.00003448471,0.00006023913,0.0000342787,0.01653605],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.01631707,"threshold_uncertainty_score":0.02295393,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07463360080466368,"score_gpt":0.3244050058909905,"score_spread":0.2497714050863268,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}